Ahmad A Bamagoos1,2,3,4, Peter A Cistulli1,2, Kate Sutherland1,2, Melanie Madronio2, Danny J Eckert4,5, Lauren Hess6, Bradley A Edwards7,8, Andrew Wellman6, Scott A Sands6. 1. Sleep Research Group, Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia. 2. Centre for Sleep Health and Research, Department of Respiratory and Sleep Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia. 3. Department of Physiology, Faculty of Medicine in Rabigh, King Abdulaziz University, Jeddah, Saudi Arabia. 4. Sleep and Breathing Lab, Neuroscience Research Australia (NeuRA), Randwick, New South Wales, Australia. 5. Adelaide Institute for Sleep Health, Flinders University, Bedford Park, South Australia, Australia. 6. Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 7. Sleep and Circadian Medicine Laboratory, Department of Physiology, and. 8. Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia.
Abstract
Rationale: Oral appliance therapy is efficacious in many patients with obstructive sleep apnea (OSA), but prediction of treatment outcome is challenging. Small, detailed physiological studies have identified key OSA endotypic traits (pharyngeal collapsibility and loop gain) as determinants of greater oral appliance efficacy. Objectives: We used a clinically applicable method to estimate OSA traits from routine polysomnography and identify an endotype-based subgroup of patients expected to show superior efficacy. Methods: In 93 patients (baseline apnea-hypopnea index [AHI], ≥20 events/h), we examined whether polysomnography-estimated OSA traits (pharyngeal: collapsibility and muscle compensation; nonpharyngeal: loop gain, arousal threshold, and ventilatory response to arousal) were associated with oral appliance efficacy (percentage reduction in AHI from baseline) and could predict responses to treatment. Multivariable regression (with interactions) defined endotype-based subgroups of "predicted" responders and nonresponders (based on 50% reduction in AHI). Treatment efficacy was compared between the predicted subgroups (with cross-validation). Results: Greater oral appliance efficacy was associated with favorable nonpharyngeal traits (lower loop gain, higher arousal threshold, and lower response to arousal), moderate (nonmild, nonsevere) pharyngeal collapsibility, and weaker muscle compensation (overall R2 = 0.30; adjusted R2 = 0.19; P = 0.003). Predicted responders (n = 54), compared with predicted nonresponders (n = 39), exhibited a greater reduction in AHI from baseline (mean [95% confidence interval], 73% [66-79] vs. 51% [38-61]; P < 0.0001) and a lower treatment AHI (8 [6-11] vs. 16 [12-20] events/h; P = 0.002). Differences persisted after adjusting for clinical covariates (including baseline AHI, body mass index, and neck circumference).Conclusions: Quantifying OSA traits using clinical polysomnography can identify an endotype-based subgroup of patients that is highly responsive to oral appliance therapy. Prospective validation is warranted.
Rationale: Oral appliance therapy is efficacious in many patients with obstructive sleep apnea (OSA), but prediction of treatment outcome is challenging. Small, detailed physiological studies have identified key OSA endotypic traits (pharyngeal collapsibility and loop gain) as determinants of greater oral appliance efficacy. Objectives: We used a clinically applicable method to estimate OSA traits from routine polysomnography and identify an endotype-based subgroup of patients expected to show superior efficacy. Methods: In 93 patients (baseline apnea-hypopnea index [AHI], ≥20 events/h), we examined whether polysomnography-estimated OSA traits (pharyngeal: collapsibility and muscle compensation; nonpharyngeal: loop gain, arousal threshold, and ventilatory response to arousal) were associated with oral appliance efficacy (percentage reduction in AHI from baseline) and could predict responses to treatment. Multivariable regression (with interactions) defined endotype-based subgroups of "predicted" responders and nonresponders (based on 50% reduction in AHI). Treatment efficacy was compared between the predicted subgroups (with cross-validation). Results: Greater oral appliance efficacy was associated with favorable nonpharyngeal traits (lower loop gain, higher arousal threshold, and lower response to arousal), moderate (nonmild, nonsevere) pharyngeal collapsibility, and weaker muscle compensation (overall R2 = 0.30; adjusted R2 = 0.19; P = 0.003). Predicted responders (n = 54), compared with predicted nonresponders (n = 39), exhibited a greater reduction in AHI from baseline (mean [95% confidence interval], 73% [66-79] vs. 51% [38-61]; P < 0.0001) and a lower treatment AHI (8 [6-11] vs. 16 [12-20] events/h; P = 0.002). Differences persisted after adjusting for clinical covariates (including baseline AHI, body mass index, and neck circumference).Conclusions: Quantifying OSA traits using clinical polysomnography can identify an endotype-based subgroup of patients that is highly responsive to oral appliance therapy. Prospective validation is warranted.
Authors: K E Bloch; A Iseli; J N Zhang; X Xie; V Kaplan; P W Stoeckli; E W Russi Journal: Am J Respir Crit Care Med Date: 2000-07 Impact factor: 21.405
Authors: Andrew Wellman; Bradley A Edwards; Scott A Sands; Robert L Owens; Shamim Nemati; James Butler; Chris L Passaglia; Andrew C Jackson; Atul Malhotra; David P White Journal: J Appl Physiol (1985) Date: 2013-01-24
Authors: Bradley A Edwards; Christopher Andara; Shane Landry; Scott A Sands; Simon A Joosten; Robert L Owens; David P White; Garun S Hamilton; Andrew Wellman Journal: Am J Respir Crit Care Med Date: 2016-12-01 Impact factor: 21.405
Authors: Kate Sutherland; Andrew S L Chan; Joachim Ngiam; Oyku Dalci; M Ali Darendeliler; Peter A Cistulli Journal: J Clin Sleep Med Date: 2018-11-15 Impact factor: 4.062
Authors: Diane C Lim; Diego R Mazzotti; Kate Sutherland; Jesse W Mindel; Jinyoung Kim; Peter A Cistulli; Ulysses J Magalang; Allan I Pack; Philip de Chazal; Thomas Penzel Journal: Sleep Med Rev Date: 2020-03-20 Impact factor: 11.609
Authors: Sara Op de Beeck; Marijke Dieltjens; Ali Azarbarzin; Marc Willemen; Johan Verbraecken; Marc J Braem; Andrew Wellman; Scott A Sands; Olivier M Vanderveken Journal: Ann Am Thorac Soc Date: 2021-03
Authors: Ritaban Dutta; Gary Delaney; Barbara Toson; Amy S Jordan; David P White; Andrew Wellman; Danny J Eckert Journal: Ann Am Thorac Soc Date: 2021-04
Authors: Sara Op de Beeck; Andrew Wellman; Marijke Dieltjens; Kingman P Strohl; Marc Willemen; Paul H Van de Heyning; Johan A Verbraecken; Olivier M Vanderveken; Scott A Sands Journal: Am J Respir Crit Care Med Date: 2021-03-15 Impact factor: 21.405
Authors: Andrey V Zinchuk; Jen-Hwa Chu; Jiasheng Liang; Yeliz Celik; Sara Op de Beeck; Nancy S Redeker; Andrew Wellman; H Klar Yaggi; Yüksel Peker; Scott A Sands Journal: Am J Respir Crit Care Med Date: 2021-09-15 Impact factor: 30.528